Abstract
Methicillin-Resistant Staphylococcus aureus (MRSA), a pathogenic bacterium that causes life-threatening outbreaks such as community-onset and nosocomial infections as emerging ‘superbug’. Time and motion study of its virulent property developed resistance against most of the antibiotics such as Vancomycin. Thereby, to curb this problem entails the development of new therapeutic agents. Plant-derived antimicrobial agents have recently piqued people's interest, so in this research, 186 flavonoids compound selected to unmask the best candidates that can act as potent inhibitors against the Penicillin Binding Protein-2a (PBP-2a) of MRSA. Molecular docking performed using PyRx and GOLD suite to determine the binding affinities and interactions between the phytochemicals and the PBP-2a. The selected candidates strongly interact with the different amino acid residues. The 30 ns molecular dynamics (MD) simulations with five top-ranked compounds such as Naringin, Hesperidin, Neohesperidin, Didymin and Icariin validated the docking interactions. These findings are also strongly supported by root-mean-square deviation, root-mean-square fluctuation and the radius of gyration. ADME/T analysis demonstrates that these candidates appear to be safer inhibitors. Our findings point to natural flavonoids as a promising and readily available source of adjuvant antimicrobial therapy against resistant strains in the future.
Communicated by Ramaswamy H. Sarma
Acknowledgements
The authors acknowledge the Department of Life Sciences, Faculty of Science & Technology, Mewar University for providing necessary infrastructure facilities. AKV acknowledges the Department of Biotechnology and Genetic Engineering, Noakhali Science and Technology University for conducting MD Simulation. SKU and AKS are thankful to the Department of Environmental Sciences, V.B.S. Purvanchal University and Department of Biotechnology MHPG College. NKV is thankful to Guru Ghasidas Vishwavidyalaya for providing technical support.
Disclosure statement
The authors declare that they have no known competing financial interests or personal relationships that have appeared to influence the work reported in this manuscript.